New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together
In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators
NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”
NCAB Member Seeks Broder’s Resignation, Gets No support
Pittsburgh Broadens Misconduct Inquiry
Senate Appropriators Plan Hearing On NCI Ouster Of Fisher
DCE director Adamson To Retire August 31
DCPC Advisor O Trial Of Cervical Lesion Management With HPV
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer
- Is psilocybin heading to a cancer clinic near you?
Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded









